Literature DB >> 4762058

Fate of emepronium in man in relation to its pharmacological effects.

A Sundwall, J Vessman, B Strindberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4762058     DOI: 10.1007/bf00558285

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  4 in total

1.  Biological fate of C14-labelled ethyl (3,3-diphenyl-l-methyl-propyl) dimethylammoniumbromide Cetiprin, a monoquaternary ammonium compound.

Authors:  E HANSSON; C G SCHMITERLOW
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1961

2.  Metabolic disposition of emepronium in the dog with a note on the relationship between plasma concentration and effect.

Authors:  A Sundwall; K Uthne; J Vessman
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1971

3.  Determination of a quaternary ammonium compound, emepronium bromide, in human urine by an ion-pair extraction method.

Authors:  S Eksborg; B A Persson; J Vessman; B Enell
Journal:  J Pharm Sci       Date:  1971-03       Impact factor: 3.534

4.  Gas chromatography and electron capture detection of benzophenone formed by chromic acid oxidation. 2. Determination of emepronium (Cetiprin), a quaternary ammonium compound in serum.

Authors:  J Vessman; S Strömberg; G Rietz
Journal:  Acta Pharm Suec       Date:  1970-09
  4 in total
  8 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  A pharmacokinetic study of neostigmine in man using gas chromatography-mass spectrometry.

Authors:  S M Aquilonius; S A Eckernäs; P Hartvig; J Hultman; B Lindström; P O Osterman
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953

3.  Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate (Multergan) in man. I. Parenteral administration.

Authors:  J H Jonkman; J Wijsbeek; R A De Zeeuw; L E Van Bork; N G Orie; A M Soeterboek; J Bender
Journal:  Pharm Weekbl Sci       Date:  1982-10-22

4.  Neuromuscular paralysis caused by an overdose of emepronium bromide (Cetiprin).

Authors:  A Ferguson; D A Baker
Journal:  Arch Emerg Med       Date:  1985-06

5.  Effect of intravenous atropine and methylatropine on heart rate and secretion of saliva in man.

Authors:  G Lönnerholm; E Widerlöv
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

6.  Pharmacokinetics and oral bioavailability of pyridostigmine in man.

Authors:  S M Aquilonius; S A Eckernäs; P Hartvig; B Lindström; P O Osterman
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

Review 7.  Current concepts in the treatment of disorders of micturition.

Authors:  K E Andersson
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

8.  The effect of parenteral emepronium bromide (Cetiprin) on postoperative vesical tenesms after transurethral resection of the prostate. A randomized, placebo-controlled study.

Authors:  L Jørgensen; H Willumsen; J R Lautorp; B Paaschburg; B Kromann; J T Andersen
Journal:  Int Urol Nephrol       Date:  1987       Impact factor: 2.370

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.